Tamehachi Namikoshi

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Jay C. Jha, Stephen P. Gray, David Barit et al. · Journal of the American Society of Nephrology · 2014 · 347 citations · Full text

Pharmacologic Inhibition, Nadph Oxidase, Renal Pathology +23

Amelioration of progressive renal injury by genetic manipulation of <i>Klotho</i> gene

Yoshisuke Haruna, Naoki Kashihara, Minoru Satoh et al. · Proceedings of the National Academy of Sciences · 2007 · 246 citations · Full text

A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo

Minoru Satoh, Naoki Kashihara, Sohachi Fujimoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 155 citations

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

Masataka Satoh, Satoshi Fujimoto, Sayaka Arakawa et al. · Nephrology Dialysis Transplantation · 2008 · 107 citations · Full text

Role of Nox2 in diabetic kidney disease

Young‐Hyun You, Shinichi Okada, San Ly et al. · American Journal of Physiology-Renal Physiology · 2013 · 89 citations · Full text

Nadph Oxidase, Individual Isoforms, Renal Pathology +21